| Drug Name |
Ranitidine hydrochloride |
| Drug ID |
BADD_D01914 |
| Description |
Ranitidine is a commonly used drug, classified as a histamine H2-receptor antagonist, and belongs to the same drug class as [cimetidine] and [famotidine]. This drug helps to prevent and treat gastric-acid associated conditions, including ulcers, because of its ability to decrease gastric acid secretion.[A176759,L10818] Ranitidine is often referred to as Zantac, and is available in various forms, including tablet, injection, and effervescent tablet preparations.[L10818,F4253]
The prevalence of GERD is thought to be 10-20% in western countries.[A176843] Ranitidine has proven to be an effective treatment for relieving uncomfortable symptoms of gastric acid associated conditions and is therefore widely used in GERD and other gastric-acid related conditions.[A176849,L10818] |
| Indications and Usage |
Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD). |
| Marketing Status |
Prescription; OTC; Discontinued |
| ATC Code |
A02BA02 |
| DrugBank ID |
DB00863
|
| KEGG ID |
D00673
|
| MeSH ID |
D011899
|
| PubChem ID |
3033332
|
| TTD Drug ID |
D0B8WN
|
| NDC Product Code |
65841-763; 72375-0002; 50090-4353; 0781-2865; 58032-2002; 68382-423; 59556-945; 67835-0004; 72785-0001; 65841-764; 70710-1550; 38779-0536; 72969-086; 73377-035; 52482-005; 55111-862; 70910-0001; 54838-550; 72643-012; 60505-2881; 55111-130; 0781-2855; 67091-244; 68382-422; 49711-0107; 38779-3186; 55111-002; 60505-0160; 49452-6214; 55111-129 |
| Synonyms |
Ranitidine | Ranitidin | N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine | Biotidin | Ranisen | Sostril | Zantac | Zantic | AH-19065 | AH 19065 | AH19065 | Ranitidine Hydrochloride | Hydrochloride, Ranitidine |
